NCT05479617

Brief Summary

In patients achieving clinical remission following a flare, artificial intelligence can reliably predict a new flare within the next 12 months utilizing clinical and objective information at day 0 and week 8. Secondary endpoints:

  • An artificial intelligence model's precision in predicting a new flare within 2 and 3 years
  • An artificial intelligence model's precision to rule out patients who will not experience a new flare within 1, 2 and 3 year

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
0mo left

Started Jun 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
Jun 2022Jul 2026

Study Start

First participant enrolled

June 20, 2022

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

June 29, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 29, 2022

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

February 27, 2025

Status Verified

February 1, 2025

Enrollment Period

3.5 years

First QC Date

June 29, 2022

Last Update Submit

February 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Flare I

    Evaluate the accuracy in predicting a flare within 1 year after the patient's initial flare using machine learning methods.

    within 1 year

Secondary Outcomes (2)

  • Flare II

    within 2 years

  • Flare III

    within 3 years

Interventions

Use of deep learning model to predict individual patients disease course

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This is a prospective cohort of a total of 400 UC patients with an active flare

You may qualify if:

  • Signed informed consent
  • Diagnosis of UC for at least 1 year
  • Relapse due to UC.

You may not qualify if:

  • Well-founded doubt that the flare is due to other than the patients UC

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gastrounit, medical section, Copenhagen University Hospital Hvidovre

Hvidovre, Denmark, 2650, Denmark

RECRUITING

Related Links

MeSH Terms

Conditions

Colitis, Ulcerative

Condition Hierarchy (Ancestors)

ColitisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesInflammatory Bowel DiseasesColonic DiseasesIntestinal Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 29, 2022

First Posted

July 29, 2022

Study Start

June 20, 2022

Primary Completion

December 1, 2025

Study Completion (Estimated)

July 1, 2026

Last Updated

February 27, 2025

Record last verified: 2025-02

Locations